Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro)

The global public health has been compromised since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in late December 2019. There are no specific antiviral drugs available to combat SARS-CoV-2 infection. Besides the rapid dissemination of SARS-CoV-2, several variants have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothan, Hussin A., Teoh, Teow Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814170/
https://www.ncbi.nlm.nih.gov/pubmed/33464543
http://dx.doi.org/10.1007/s12033-021-00299-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814170/
https://www.ncbi.nlm.nih.gov/pubmed/33464543
http://dx.doi.org/10.1007/s12033-021-00299-7

Ejemplares similares